Home › Pagdurugo sa Utak › Texas
Pag-aaral pangklinika para sa Pagdurugo sa Utak sa Texas
6 pag-aaral para sa Pagdurugo sa Utak ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
- University of Texas Medical Branch, Galveston
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- at 1 pa
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07260916Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
- Houston Methodist Research Institute, Houston
- UTHealth, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04916210Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
- Memorial Hermann Memorial City Medical Center, Houston
- Memorial Hermann-Texas Medical Center, Houston
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07227246Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- UT Southwestern Medical Center, Dallas
- University of Texas Health Science Center San Antonio, San Antonio
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06402968Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- University of Texas Health Science Center San Antonio, San Antonio
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT03907046Effect of the Stellate Ganglion Block on the Retinal Microcirculation
- UT Southwestern Medical Center, Dallas
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 19, 2025 · NCT06797752Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.